[go: up one dir, main page]

WO2005051320A3 - Gck utilises comme modificateurs de la morphogenese de ramification et leurs methodes d'utilisation - Google Patents

Gck utilises comme modificateurs de la morphogenese de ramification et leurs methodes d'utilisation Download PDF

Info

Publication number
WO2005051320A3
WO2005051320A3 PCT/US2004/039550 US2004039550W WO2005051320A3 WO 2005051320 A3 WO2005051320 A3 WO 2005051320A3 US 2004039550 W US2004039550 W US 2004039550W WO 2005051320 A3 WO2005051320 A3 WO 2005051320A3
Authority
WO
WIPO (PCT)
Prior art keywords
branching morphogenesis
methods
gcks
modifiers
gck
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/039550
Other languages
English (en)
Other versions
WO2005051320A2 (fr
Inventor
Hinrich Alexander Habeck
Felix D Karim
Thomas I Koblizek
Ulrike Langheinrich
Gregory D Plowman
Merker Staefan Schulte
Gordon Mark Stott
Candace Swimmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of WO2005051320A2 publication Critical patent/WO2005051320A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005051320A3 publication Critical patent/WO2005051320A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des gènes GCK humains identifiés comme modulateurs de la morphogenèse de ramification, et, par conséquent, utiles comme cibles thérapeutiques pour des affections associées à une fonction de morphogenèse de ramification déficiente. L'invention concerne également des méthodes destinées à identifier des modulateurs de la morphogenèse de ramification et consistant à cribler des agents modulant l'activité GCK.
PCT/US2004/039550 2003-11-24 2004-11-23 Gck utilises comme modificateurs de la morphogenese de ramification et leurs methodes d'utilisation Ceased WO2005051320A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52455003P 2003-11-24 2003-11-24
US60/524,550 2003-11-24

Publications (2)

Publication Number Publication Date
WO2005051320A2 WO2005051320A2 (fr) 2005-06-09
WO2005051320A3 true WO2005051320A3 (fr) 2006-10-12

Family

ID=34632906

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2004/039790 Ceased WO2005052132A2 (fr) 2003-11-24 2004-11-22 Utilisation de modulateurs de la morphogenese de ramification comme genes modificateurs de la morphogenese de ramification et leurs procedes d'utilisation
PCT/US2004/039408 Ceased WO2005051314A2 (fr) 2003-11-24 2004-11-23 Genes irak utilises en tant que modificateurs de morphogenese de ramification et procedes d'utilisation associes
PCT/US2004/039550 Ceased WO2005051320A2 (fr) 2003-11-24 2004-11-23 Gck utilises comme modificateurs de la morphogenese de ramification et leurs methodes d'utilisation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PCT/US2004/039790 Ceased WO2005052132A2 (fr) 2003-11-24 2004-11-22 Utilisation de modulateurs de la morphogenese de ramification comme genes modificateurs de la morphogenese de ramification et leurs procedes d'utilisation
PCT/US2004/039408 Ceased WO2005051314A2 (fr) 2003-11-24 2004-11-23 Genes irak utilises en tant que modificateurs de morphogenese de ramification et procedes d'utilisation associes

Country Status (1)

Country Link
WO (3) WO2005052132A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0809069D0 (en) 2008-05-19 2008-06-25 Univ Leuven Kath Gene signatures
GEP20135783B (en) 2008-05-16 2013-03-11 Takeda California Inc Glucokinase activators
KR101300540B1 (ko) * 2009-01-07 2013-09-02 하이동 후앙 인간 글루코키나제 돌연변이체 코딩 유전자, 이에 의하여 코딩된 효소, 재조합 벡터 및 숙주, 이의 약학적 조성물 및 용도, 및 질병의 예방 및 치료 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654397A (en) * 1985-06-23 1997-08-05 Tularik, Inc. Interleukin-1 receptor-associated protein kinase and assays
CA2107682A1 (fr) * 1991-04-10 1992-10-11 Javier Navarro Recepteurs de l'interleukine 8, molecules apparentees et methodes
US20020026037A1 (en) * 1995-06-06 2002-02-28 Jing-Shan Hu Vascular endothelial growth factor 3 antibodies
WO1997000690A1 (fr) * 1995-06-23 1997-01-09 Tularik, Inc. Proteine kinase associee au recepteur de l'interleukine-1 et dosages
US20030064917A1 (en) * 1998-07-23 2003-04-03 Crawford Susan E. Methods and compositions for inhibiting angiogenesis
US6365356B1 (en) * 1999-03-17 2002-04-02 Cornell Research Foundation, Inc. Receptors that regulate cell signaling relating to chemokines
US6818419B2 (en) * 2000-01-13 2004-11-16 Tularik Inc. IRAK-4: compositions and methods of use
DE60237917D1 (de) * 2001-06-05 2010-11-18 Exelixis Inc Gfats als modifikatoren des p53-wegs und verwendungsverfahren
AU2002362020A1 (en) * 2001-11-26 2003-06-10 Exelixis, Inc. CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RIZZO M.A.: "A Funtional Link Between Glucokinase Binding to Insulin Granules and Conformational Alterations in Response to Glucose and Insulin", J.BIOL.CHEM., vol. 277, no. 37, September 2002 (2002-09-01), pages 34168 - 34175 *

Also Published As

Publication number Publication date
WO2005051314A2 (fr) 2005-06-09
WO2005052132A3 (fr) 2007-06-07
WO2005052132A2 (fr) 2005-06-09
WO2005051314A3 (fr) 2007-04-26
WO2005051320A2 (fr) 2005-06-09

Similar Documents

Publication Publication Date Title
WO2003045321A3 (fr) Mbm en tant que modificateurs de morphogenese par ramification et procedes d'utilisation
WO2005016287A3 (fr) Prkwnk utilises en tant que modificateurs de la voie rac et methodes d'utilisation associees
WO2004038371A3 (fr) Ccr8 (recepteur de chimiokines 8) utilise comme modificateur d'une morphogenese de ramification et procedes d'utilisation
WO2006009962A3 (fr) Acacs utilises comme genes modificateurs de la voie igf et leurs procedes d'utilisation
WO2005002418A3 (fr) Mpten en tant que modulateurs du passage pten/igf et procedes d'utilisation
WO2005051320A3 (fr) Gck utilises comme modificateurs de la morphogenese de ramification et leurs methodes d'utilisation
WO2004024882A3 (fr) Flj20647 utilise en tant que modificateur de la voie p21 et procedes d'utilisation associes
WO2005003297A3 (fr) Genes mpten utilises en tant que modificateurs de la voie pten/igf et procedes d'utilisation associes
WO2004013309A3 (fr) Papss comme modificateurs de la voie d'axin et procédés d'utilisation
WO2006009928A3 (fr) Galnts comme modificateurs du chemin igfr et procedes d'utilisation
WO2004037990A3 (fr) Genes mbm en tant que modificateurs de la morphogenese ramifiee et leurs procedes d'utilisation
WO2004005483A3 (fr) Adcy3s modificateurs de la voie p21 et methodes d'utilisation
WO2005072470A3 (fr) Genes mbm en tant que modificateurs de la morphogenese de ramification et methodes d'utilisation
WO2003045314A3 (fr) Mhyps comme modificateurs de morphogenese de ramification et procedes d'utilisation
WO2005003303A3 (fr) Genes nadk utilises comme modificateurs de la morphogenese de ramification et procedes d'utilisation
WO2004005484A3 (fr) Snrks utilises comme modificateurs de chk et de la morphogenese de branchement et leurs procedes d'utilisation
WO2004014301A3 (fr) Genes psmc utilises comme modificateurs du trajet retiniblastome (rb) et techniques d'utilisation
WO2005017123A3 (fr) Mptens utilises comme modificateurs de la voie pten et procedes d'utilisation
WO2004015071A3 (fr) Genes csnk1gs utilises en tant que modificateurs de la voie p21 et procede d'utilisation associe
WO2005090992A3 (fr) Genes mpten modifiant le trajet pten, et procedes d'utilisation
WO2004048538A3 (fr) Caseine kinases modifiant la voie rac et leurs procedes d'utilisation
WO2004024891A3 (fr) Genes mbm en tant que modificateurs de la morphogenese ramifiee et leurs procedes d'utilisation
WO2004048541A3 (fr) Cct6 utilises comme modificateurs de la voie rb, et procedes d'utilisation correspondants
WO2004083389A3 (fr) Genes mbcat utilises comme modificateurs de la voie de la beta-catenine et techniques d'utilisation
WO2005001026A3 (fr) Adenosines kinases en tant que modificateurs de la voie pten et leurs procedes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase